The Covid-19 pandemic is reshaping almost every aspect of our society, including our healthcare systems. In this global emergency, in which the coronavirus continues its inexorable spread with a disproportionate impact on communities of color, the urgent search for effective therapeutics and an effective vaccine has led to unprecedented collaborations between healthcare and drug companies, academic researchers, nonprofits and governments. Even so, some stresses to this collaborative approach are evident, such as governments eager to secure first treatments and potential vaccines for their domestic populations.
How will this ongoing crisis continue to shape the evolution of the clinical and research ecosystem to combat future health care challenges? How can we make systemic changes to close the gaps in access to care laid bare by the pandemic? How are institutional investors, including VC and PE firms, deploying capital to biotech startups? How can we create greater incentives (and reduce the disincentives) to spur research to meet these needs? And looking further ahead, how can executives, researchers and policy makers take the lessons learned from the early days of this crisis to more broadly rethink approaches to health care?
August 13 - Thursday
President & Chief Executive Officer, PhRMA
In Conversation with...
Bloomberg Intelligence Presentation
Director of Research, Bloomberg Intelligence, Bloomberg
The Race to Solve the Covid-19 Crisis
Dr Seth Berkley
CEO, Gavi, The Vaccine Alliance
The Next Health Care Threat
Founding Director, MRC Centre for Global Infectious Disease Analysis, Imperial College London
Founding Director, Global Health Governance Programme, Professor, University of Edinburgh Medical School
Chief Scientist, World Health Organization
Senior Executive Editor, Bloomberg
Neil FergusonFounding Director, MRC Centre for Global Infectious Disease Analysis Imperial College London
Devi SridharFounding Director, Global Health Governance Programme Professor, University of Edinburgh Medical School
Soumya SwaminathanChief Scientist World Health Organization
Stephen UblPresident & Chief Executive Officer PhRMA
John FraherSenior Executive Editor Bloomberg
Sam FazeliDirector of Research, Bloomberg Intelligence Bloomberg
Dr Seth BerkleyCEO Gavi, The Vaccine Alliance
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than $900 billion in the search for new treatments and cures, including an estimated $79.6 billion in 2018 alone.